Bill Text: HI SB940 | 2021 | Regular Session | Introduced
Bill Title: Relating To Opioids.
Spectrum: Partisan Bill (Democrat 7-0)
Status: (Introduced - Dead) 2021-01-29 - Referred to HTH, CPN/JDC. [SB940 Detail]
Download: Hawaii-2021-SB940-Introduced.html
|
THE SENATE |
S.B. NO. |
940 |
|
THIRTY-FIRST LEGISLATURE, 2021 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to opioids.
BE IT
ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 329, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§329- Opioids; initial prescriptions; acute pain;
verbal discussion. (a) Prior to issuing the initial prescription of
a controlled substance that is an opioid in a course of treatment for acute
pain, and again prior to issuing the third prescription of the course of
treatment for the same acute pain symptom, a provider authorized to prescribe
opioids shall discuss with the patient, or the patient's parent or guardian if
the patient is under eighteen years of age and is not an emancipated minor, the
risks associated with the opioid being prescribed, including but not limited
to:
(1) The risks of addiction and overdose
associated with opioids and the dangers of taking opioids with alcohol,
benzodiazepines, and other central nervous system depressants;
(2) The reasons why the prescription is
necessary;
(3) Alternative treatments that may be
available; and
(4) Risks associated with the use of the opioids
being prescribed, specifically that:
(A) Opioids are highly addictive, even when
taken as prescribed;
(B) There is a risk of developing a physical or
psychological dependence on the controlled dangerous substance; and
(C) The risks of taking more opioids than
prescribed, or mixing sedatives, benzodiazepines, or alcohol with opioids, can
result in fatal respiratory depression.
(b) The provider shall document that he or she has
discussed with the patient or the patient's parent or guardian, as applicable, the
risks of developing a physical or psychological dependence on the opioid and alternative
treatments that may be available through use of the existing department of health's
informed consent form. The department of
health may make any changes on the informed consent form to reflect this explicit
requirement for a verbal discussion that it deems necessary or leave the form unamended
if it concludes it is sufficient in its current form. The department of health may
develop and make available guidelines for the discussion required pursuant to this
section.
(c) As used in this section:
"Acute
pain" means pain, whether resulting from a disease, accidental or
intentional trauma, or other cause, that the provider reasonably believes
expects to last only a short period of time.
"Acute pain" does not include chronic pain, pain originating
from cancer, pain experienced while the patient is in palliative care or
hospice care, or pain experienced by a qualified patient under chapter 327L.
"Initial
prescription" means a prescription issued to a patient who:
(1) Has never previously been issued a
prescription for the opioid; or
(2) Was previously issued a prescription for
the opioid, but the date on which the current prescription is being issued is
more than one year after the date the patient last used or was administered the
opioid.
When
determining whether a patient was previously issued a prescription for an
opioid, the provider shall consult with the patient and review the patient's
medical record and the State prescription accountability system."
SECTION 2. New statutory material is underscored.
SECTION 3. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Opioids; Initial Prescription; Acute Pain; Providers; Verbal Discussion; Risks
Description:
Requires providers authorized to prescribe opioids to discuss with patients certain risks associated with controlled substances that are opioids prior to issuing initial opioid prescriptions for the treatment of acute pain. Requires providers to include a note acknowledging the discussion of the risks associated with opioids in the patient's medical record.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
